← Back to Search

Duodenoscope with Single-use Distal Cover for Biliary Tract Cancer

Stanford hospital, Palo Alto, CA

Targeting 6 different conditionsDuodenoscope with single-use distal cover +1 moreN/ARecruitingLed by Subhas Banerjee, MDResearch Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients undergoing ERCP for biliary and pancreatic conditions

Be older than 18 years old

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up3 months

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will compare the success and complication rates of two types of endoscopes currently used for a procedure called ERCP.

Eligible Conditions

Pancreatic Disease
Biliary Tract Cancer
Gallstone Disease
Biliary Disease
Biliary Obstruction
Pancreatic Cancer

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You are having an ERCP procedure done for issues with your bile ducts or pancreas.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with procedure-related adverse events

Secondary outcome measures

Ability to perform interventions

Duodenoscope imaging characteristics profile

Duodenoscope maneuverability

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Conventional DuodenoscopeActive Control1 Intervention

Patients will undergo ERCP using a conventional duodenoscope

Group II: Duodenoscope with single-use distal coverActive Control1 Intervention

Patients will undergo ERCP using a duodenoscope with a single-use distal cover

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,324 Previous Clinical Trials

17,287,358 Total Patients Enrolled

Subhas Banerjee, MDPrincipal InvestigatorStanford University

1 Previous Clinical Trials

50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been invited to partcipate in this clinical research?

"Indeed, clinicaltrials.gov data reveals that this research is actively recruiting patients. The trial was first posted on October 25th 2022 and has been updated recently on the 24th of October 2022. 600 participants are being sought at a single medical centre."

Answered by AI

Are there any openings to partake in this trial at present?

"In accordance with clinicaltrials.gov, this trial is actively enlisting participants; the study was posted on October 25th 2022 and its details were updated most recently on October 24th 2022."

Answered by AI

Recent research and studies

Digestive EndoscopyJournal

Prospective Evaluation of an Assessment Tool for Technical Performance of Duodenoscopes

Bang, Ji Young, Thomas Rösch, Hyungjin Myra Kim, Shyam Thakkar, Ernesto Robalino Gonzaga, Benjamin Tharian, Sumant Inamdar, et al.. 2020. “Prospective Evaluation of an Assessment Tool for Technical Performance of Duodenoscopes”. Digestive Endoscopy. Wiley. doi:10.1111/den.13856.

clinicaltrials.govStudy

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Subhas Banerjee 2022. "Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05429203.

All > Pancreas Cancer > Pancreatic Cancer